Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Measurement of Neutrino Oscillation Parameters with 10 Years of Data from the NOvA Experiment.

Physical review letters·2026
Same author

Dual-Baseline Search for Active-to-Sterile Neutrino Oscillations in NOvA.

Physical review letters·2025
Same author

Studies on the significance of secretory IgA antibodies in the pathogenesis and clinical course of enterobiasis in infected persons from Bulgaria: preliminary findings.

Helminthologia·2025
Same author

Search for CP-Violating Neutrino Nonstandard Interactions with the NOvA Experiment.

Physical review letters·2024
Same author

INFLAMMATORY FACTORS IN DISSECTION OF THORACIC AORTIC ANEURYSM.

Georgian medical news·2024
Same author

Comparison of Preimplantation Mouse Embryos with Different Genetic Backgrounds as Models for Evaluating Human Embryo Culture Media Composition.

Reproductive sciences (Thousand Oaks, Calif.)·2024
Same journal

An Adaptive Biomarker-based Umbrella Trial Design Using Bayesian Latent Class Model.

Statistics in biopharmaceutical research·2026
Same journal

A Bayesian Adaptive Marker-Stratified Design for Phase II Clinical Trials Using Calibrated Spike-and-Slab priors.

Statistics in biopharmaceutical research·2026
Same journal

On the Two-Step Hybrid Design for Augmenting Randomized Trials Using Real-World Data.

Statistics in biopharmaceutical research·2025
Same journal

Two-stage Adaptive Enrichment Designs with Survival Outcomes and Adjustment for Misclassification in Predictive Biomarkers.

Statistics in biopharmaceutical research·2025
Same journal

A novel longitudinal rank-sum test for multiple primary endpoints in clinical trials: Applications to neurodegenerative disorders.

Statistics in biopharmaceutical research·2025
Same journal

Isotonic Phase I cancer clinical trial design utilizing patient-reported outcomes.

Statistics in biopharmaceutical research·2025
See all related articles

Related Experiment Video

Updated: Feb 2, 2026

Dissolution Dynamic Nuclear Polarization Instrumentation for Real-time Enzymatic Reaction Rate Measurements by NMR
10:54

Dissolution Dynamic Nuclear Polarization Instrumentation for Real-time Enzymatic Reaction Rate Measurements by NMR

Published on: February 23, 2016

11.2K

Comment.

A Ivanova1, K M Anderson2, Gary L Rosner3

  • 1Department of Biostatistics, University of North Carolina at Chapel Hill, NC, USA.

Statistics in Biopharmaceutical Research
|November 13, 2018
PubMed
Summary
This summary is machine-generated.

Innovative drug development strategies accelerate safe and effective treatments. This commentary explores novel clinical trial designs, including extended Phase I trials and single-arm studies, to optimize therapeutic delivery.

More Related Videos

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

5.8K
Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

1.2K

Related Experiment Videos

Last Updated: Feb 2, 2026

Dissolution Dynamic Nuclear Polarization Instrumentation for Real-time Enzymatic Reaction Rate Measurements by NMR
10:54

Dissolution Dynamic Nuclear Polarization Instrumentation for Real-time Enzymatic Reaction Rate Measurements by NMR

Published on: February 23, 2016

11.2K
Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

5.8K
Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

1.2K

Area of Science:

  • Clinical trial design
  • Drug development strategies

Background:

  • Traditional drug development models are being challenged by innovative approaches.
  • Breakthrough therapies with exceptional early efficacy data necessitate accelerated development pathways.
  • Ethical considerations, such as patient crossover in randomized controlled studies, arise with accelerated approaches.

Purpose of the Study:

  • To comment on innovative approaches in drug development.
  • To discuss the implications of non-proportional hazards in clinical trials.
  • To evaluate the interpretability and utility of extended Phase I trials and single-arm trials for drug approval.
  • To review recent innovations in clinical trial design.

Main Methods:

  • Review and commentary on existing literature and proposed innovative trial designs.
  • Analysis of four key topics: non-proportional hazards, extended Phase I trials, single-arm trials, and novel trial designs.

Main Results:

  • The commentary addresses the potential and challenges of innovative drug development approaches.
  • Specific focus on the utility of extended Phase I and single-arm trials for regulatory approval.
  • Discussion on the importance of understanding the successes and limitations of new methodologies.

Conclusions:

  • Innovative clinical trial designs can expedite the delivery of safe and effective treatments.
  • Careful consideration of methodologies like non-proportional hazards and single-arm trials is crucial for successful drug development.
  • Further understanding of the pitfalls and successes of novel approaches is essential for optimizing patient outcomes.